BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15763196)

  • 1. Uveal melanoma: proton beam irradiation.
    Gragoudas ES; Marie Lane A
    Ophthalmol Clin North Am; 2005 Mar; 18(1):111-8, ix. PubMed ID: 15763196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute.
    Höcht S; Bechrakis NE; Nausner M; Kreusel KM; Kluge H; Heese J; Heufelder J; Cordini D; Homeyer H; Fuchs H; Martus P; Foerster MH; Wiegel T; Hinkelbein W
    Strahlenther Onkol; 2004 Jul; 180(7):419-24. PubMed ID: 15241529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior uveal melanoma in young patients treated with proton beam therapy.
    Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
    Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam therapy for the treatment of uveal melanoma in Scotland.
    Macdonald EC; Cauchi P; Kemp EG
    Br J Ophthalmol; 2011 Dec; 95(12):1691-5. PubMed ID: 21216794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
    Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
    Marucci L; Ancukiewicz M; Lane AM; Collier JM; Gragoudas ES; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):842-6. PubMed ID: 20472356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Report on the conservative treatment of melanoma of the uvea at the Lausanne University Ophthalmologic Clinic].
    Zografos L; Gailloud C; Perret C; Uffer S; Raimondi S; Chamot L; Carrel S; Greiner R
    Klin Monbl Augenheilkd; 1988 May; 192(5):572-8. PubMed ID: 3404968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton beam therapy and iris neovascularisation in uveal melanoma.
    Boyd SR; Gittos A; Richter M; Hungerford JL; Errington RD; Cree IA
    Eye (Lond); 2006 Jul; 20(7):832-6. PubMed ID: 16167079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for uveal malignant melanoma.
    Shields CL; Shields JA; Gündüz K; Freire JE; Mercado G
    Ophthalmic Surg Lasers; 1998 May; 29(5):397-409. PubMed ID: 9599365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homolateral episcleral metastasis or surgical seeding of a proton-irradiated ciliary body melanoma?].
    Daicker B; Zografos L; Müller O
    Klin Monbl Augenheilkd; 1988 May; 192(5):579-81. PubMed ID: 2841533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Double irradiation for macroscopic radioresistance or recurrence of melanomas of the posterior uvea: clinical, ballistic, therapeutic and prognostic aspects. Series of 19 cases among 462 patients].
    Grange JD; Duquesne N; Roubeyrol F; Branisteanu D; Sandon K; Fleury J; Gerard JP; Chauvel P; Pinzaru G; Jean-Louis B; Bievelez B
    J Fr Ophtalmol; 1999 Dec; 22(10):1054-63. PubMed ID: 10617843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and technical requirements for proton treatment planning of ocular diseases. The SERAG (South Europe Radiotherapy Group).
    Chauvel P; Sauerwein W; Bornfeld N; Friedrichs W; Brassart N; Courdi A; Hérault J; Pignol JP; Bondiau PY; Malandain G
    Front Radiat Ther Oncol; 1997; 30():133-42. PubMed ID: 9205893
    [No Abstract]   [Full Text] [Related]  

  • 15. Proton beam irradiation of uveal melanomas at Paul Scherrer Institute (former SIN).
    Zografos L; Perret C; Egger E; Gailloud C; Greiner R
    Strahlenther Onkol; 1990 Jan; 166(1):114. PubMed ID: 2154044
    [No Abstract]   [Full Text] [Related]  

  • 16. [The proton radiotherapy of melanoma of the uvea. The technic, methodology and first clinical observations].
    Vitale V; Scolaro T; Andreucci L; Foppiano F; Porta A; Mosci C; Ravazzoni L; Brassart N; Chauvel P
    Radiol Med; 1992 Nov; 84(5):630-5. PubMed ID: 1335591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ring recurrence of ciliary body melanoma after proton-beam therapy].
    Meyer A; D'Hermies F; Korobelnik JF; Morel X; Elmaleh C; Renard G
    J Fr Ophtalmol; 1997; 20(9):697-700. PubMed ID: 9587582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiation pathomorphosis of malignant melanoma of the uveal tract of the human eye].
    Vit VV
    Oftalmol Zh; 1989; (6):321-5. PubMed ID: 2622594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton treatment of uveal melanomas.
    Bornfeld N
    Strahlenther Onkol; 2007 Jan; 183(1):1-2. PubMed ID: 17225938
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of ciliochoroidal melanomas with a medical narrow proton beam].
    Brovkina AF; Zarubeĭ GD
    Vestn Oftalmol; 1986; 102(3):30-3. PubMed ID: 3014703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.